Joint CDC and FDA Statement on Johnson & Johnson (JNJ) COVID-19 Vaccine

Go back to Joint CDC and FDA Statement on Johnson & Johnson (JNJ) COVID-19 Vaccine

Johnson & Johnson (JNJ) Vaccine Pause Expected to be Matter of Days, Says FDA

April 13, 2021 10:17 AM EDT

Johnson & Johnson (NYSE: JNJ) Vaccine Pause Expected to be Matter of Days, Says FDA

... More

Johnson & Johnson (JNJ) Statement on COVID-19 Vaccine

April 13, 2021 9:22 AM EDT

Johnson & Johnson (NYSE: JNJ) announced:

The safety and well-being of the people who use our products is our number one priority. We are aware of an extremely rare disorder involving people with blood clots in combination with low platelets in a small number of individuals who have... More

U.S. Calls for Pause of J&J (JNJ) Vaccine After Clotting Cases, Including One Death

April 13, 2021 7:00 AM EDT

(Updated - April 13, 2021 7:06 AM EDT)

The FDA and CDC on Tuesday called for an immediate pause in the use of J&J's (NYSE: JNJ) coronavirus vaccine after six recipients in the U.S. developed a rare disorder involving blood clots within about two... More